Review




Structured Review

Dade Behring diff-quick fixative solutions
Diff Quick Fixative Solutions, supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diff-quick+fixative+solutions/diff+quick+fixative+solutions/pmc04741658__oncotarget___06___32039___s001-21-13-16
Average 90 stars, based on 1 article reviews
diff-quick fixative solutions - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Incubation:

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: After 48 h, Matrigel-coated inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
Article Snippet: After 24 h of incubation, cells were fixed with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Article Snippet: Cells were fixed after 24 h of incubation with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Article Snippet: After 24 h, migration inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: After 24 h, migration inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
Article Snippet: Transwell Invasion Assay For invasion assay, 1 × 10 5 cells were plated in the top chamber onto the Matrigel-coated membrane (24-well insert; pore size, 8 μm; Corning Costar).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: Cells were fixed after 24 h of incubation with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Staining:

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: After 48 h, Matrigel-coated inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
Article Snippet: After 24 h of incubation, cells were fixed with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Article Snippet: Cells were fixed after 24 h of incubation with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Article Snippet: After 24 h, migration inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: After 24 h, migration inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
Article Snippet: Transwell Invasion Assay For invasion assay, 1 × 10 5 cells were plated in the top chamber onto the Matrigel-coated membrane (24-well insert; pore size, 8 μm; Corning Costar).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: Cells were fixed after 24 h of incubation with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Diff-Quik:

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: After 48 h, Matrigel-coated inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
Article Snippet: After 24 h of incubation, cells were fixed with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Article Snippet: Cells were fixed after 24 h of incubation with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Article Snippet: After 24 h, migration inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: After 24 h, migration inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
Article Snippet: Transwell Invasion Assay For invasion assay, 1 × 10 5 cells were plated in the top chamber onto the Matrigel-coated membrane (24-well insert; pore size, 8 μm; Corning Costar).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: Cells were fixed after 24 h of incubation with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Migration:

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: After 48 h, Matrigel-coated inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
Article Snippet: After 24 h of incubation, cells were fixed with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Article Snippet: Cells were fixed after 24 h of incubation with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Article Snippet: After 24 h, migration inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: After 24 h, migration inserts were fixed and stained with Diff-Quick Fixative Solutions (Dade Behring).

Article Title: NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
Article Snippet: Transwell Invasion Assay For invasion assay, 1 × 10 5 cells were plated in the top chamber onto the Matrigel-coated membrane (24-well insert; pore size, 8 μm; Corning Costar).

Article Title: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
Article Snippet: Cells were fixed after 24 h of incubation with methanol and stained with Diff-Quick Fixative Solutions (Dade Behring, Newark, DE, USA).



Similar Products

90
Reagena Ltd quick diff fix solution
Quick Diff Fix Solution, supplied by Reagena Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diff-quick+fixative+solutions/quick+diff+fix+solution/pm37887280-80-10-14
Average 90 stars, based on 1 article reviews
quick diff fix solution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Gamidor Technical Services Ltd reastain quick diff fix solution
Reastain Quick Diff Fix Solution, supplied by Gamidor Technical Services Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diff-quick+fixative+solutions/diff+quick/pm32162287-48-10-15
Average 90 stars, based on 1 article reviews
reastain quick diff fix solution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Medion Diagnostics diff-quick fix solution
Diff Quick Fix Solution, supplied by Medion Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diff-quick+fixative+solutions/diff+quick/pmc04922703-388-21-22
Average 90 stars, based on 1 article reviews
diff-quick fix solution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Dade Behring diff-quick fixative solutions
Diff Quick Fixative Solutions, supplied by Dade Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diff-quick+fixative+solutions/diff+quick+fixative+solutions/pmc04741658__oncotarget___06___32039___s001-21-13-16
Average 90 stars, based on 1 article reviews
diff-quick fixative solutions - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results